相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Membrane lipids: where they are and how they behave
Gerrit van Meer et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Tumor necrosis factor α mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response
Ann L. B. Seynhaeve et al.
CANCER RESEARCH (2007)
Early in vivo assessment of angiostatic therapy efficacy by molecular MRI
Willem J. M. Mulder et al.
FASEB JOURNAL (2007)
Lipid rafts: at a crossroad between cell biology and physics
Ken Jacobson et al.
NATURE CELL BIOLOGY (2007)
Sphingosine, a product of ceramide hydrolysis, influences the formation of ceramide channels
Matthew J. Elrick et al.
BIOPHYSICAL JOURNAL (2006)
Phase II study of the combination of pegylated liposomal doxorubicin and topotecan in platinum-resistant ovarian cancer
M Verhaar-Langereis et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2006)
Coformulated N-octanoyl-glucosylceramide improves cellular delivery and cytotoxicity of liposomal doxorubicin
RJ Veldman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticle
WJM Mulder et al.
FASEB JOURNAL (2005)
Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors
KM Laginha et al.
CLINICAL CANCER RESEARCH (2005)
Sphingosine forms channels in membranes that differ greatly from those formed by ceramide
LJ Siskind et al.
JOURNAL OF BIOENERGETICS AND BIOMEMBRANES (2005)
N-hexanoyl-sphingomyelin potentiates in vitro doxorubicin cytotoxicity by enhancing its cellular influx
RJ Veldman et al.
BRITISH JOURNAL OF CANCER (2004)
The role of the liposomal anthracyclines and other systemic therapies in the management of advanced breast cancer
NJ Robert et al.
SEMINARS IN ONCOLOGY (2004)
Use of liposomal anthracyclines in Kaposi's sarcoma
SE Krown et al.
SEMINARS IN ONCOLOGY (2004)
Role of liposomal anthracyclines in the treatment of multiple myeloma
MA Hussein et al.
SEMINARS IN ONCOLOGY (2004)
Cardiac safety of liposomal anthracyclines
MS Ewer et al.
SEMINARS IN ONCOLOGY (2004)
Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials
DS Alberts et al.
SEMINARS IN ONCOLOGY (2004)
Advantages of liposomal delivery systems for anthracyclines
TM Allen et al.
SEMINARS IN ONCOLOGY (2004)
Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of pegylated liposomal doxorubicin formulations in murine breast cancer
GJR Charrois et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2004)
Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin
RM Schiffelers et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Ceramide: second messenger or modulator of membrane structure and dynamics?
WJ van Blitterswijk et al.
BIOCHEMICAL JOURNAL (2003)
Pharmacokinetics of pegylated liposomal doxorubicin - Review of animal and human studies
A Gabizon et al.
CLINICAL PHARMACOKINETICS (2003)
Ligand-targeted therapeutics in anticancer therapy
TM Allen
NATURE REVIEWS CANCER (2002)
The endocytic pathway: A mosaic of domains
J Gruenberg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
H Maeda et al.
JOURNAL OF CONTROLLED RELEASE (2000)
分享论文
